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ABSTRACT 
Objective: To synthesize, characterize and evaluate starch xanthate as a superdisintegrant in the formulation of fast dissolving tablets by employing 
23
Methods: Starch xanthate was synthesized by gelatinization process. The physical and micromeritic properties were performed to evaluate the 
synthesized starch xanthate. The fast dissolving tablet of ibuprofen was prepared by employing starch xanthate as a superdisintegrant in different 
proportions in each case by direct compression method using 2
 factorial design. 
3 factorial design. The drug content, hardness, friability, disintegration time and 
other dissolution characteristics like percent dissolved in 5 min (PD5), dissolution efficiency in 5 min (DE5%) and first order rate constant (K1
Results: The starch xanthate prepared was found to be fine, free flowing slightly crystalline powder. Starch xanthate exhibited good swelling in 
water. The study between ibuprofen and starch xanthate was shown the absence of interaction by fourier transform infrared spectra (FTIR) and 
differential scanning calorimetry (DSC). The drug content (100±5%), hardness (3.6–4 kg/sq. cm), and friability (0.12-0.15%) has been effective with 
regard to all the formulated fast dissolving tablets employing starch xanthate. The disintegration time of all the formulated tablets was found to be 
in the range of 12±0.01 to 312±0.02s. The optimized formulation F5 has the least disintegration time i.e., 12±0.01s. The In vitro wetting time of the 
formulated tablets was found to be in the range of 76±0.21 to 217±0.17s. The In vitro wetting time was less (i.e., 90s) in optimized formulation F5. 
The water absorption ratio of the formulated tablets was found to be in the range of 16±0.16 to 174±0.21%. The cumulative drug dissolved in the 
optimized formulation F5 was found to be 99.83±0.56% in 5 min.  
) 
were used in the evaluation of prepared fast dissolving tablets. 
Conclusion: The dissolution efficiency of ibuprofen was enhanced when starch xanthate was found to be a superdisintegrant when combined with 
sodium starch glycolate, croscarmellose sodium and, hence it could be used in the formulation of fast dissolving tablets to provide immediate 
release of the contained drug within 5 min. 
Keywords: Fast dissolving, Superdisintegrant, Starch xanthate, Dissolution efficiency 




Under the category of solid dosage forms, the fast dissolving tablets are 
containing indicated substances which disintegrate rapidly, usually 
within a few seconds when placed upon tongue requiring additional 
water to facilitate swallowing. Fast dissolving tablets contribute 
immense advantages for the patients having difficulty in swallowing. It 
has been reported that dysphasia (difficulty in swallowing) is usual 
among all groups and more specific with pediatric, geriatric population 
along with patients have nausea, retching, and motion sickness 
complications [1]. Fast dissolving tablets overcome this problem and 
provide the advantages for pediatrics, geriatric [2], bedridden, disabled 
patients and also for who may have difficulty in swallowing tablets, 
capsules, and liquid orals. Fast dissolving tablets (FDT) will disintegrate 
rapidly in the mouth without the need of water [3-4]. Fast dissolving 
tablet formulation provides sufficient strength, quick disintegration/ 
dissolution in the mouth without water [5], rapid dissolution and 
absorption of the drug, which will produce the quick onset of action. Pre 
gastric absorption of FDT can result in improved bioavailability and as a 
consequence of reduced dose [6]. Various techniques can be used to 
formulate fast dissolving tablets. To achieve fast tablet disintegration, 
direct compression is one of the techniques used in the incorporation of 
superdisintegrant or highly water-soluble excipients into the 
formulation. Direct compression is the ideal method for moisture and 
heat-liable medication and does not require the use of water or heat 
during the formulation procedure. The aim of the work was to formulate 
and characterize fast-dissolving tablets of ibuprofen by utilizing 
optimization techniques for rapid dissolution of drug and absorption 
employing a new superdisintegrant i.e., starch xanthate. 
The selection of several experimental and manufacturing steps for a 
given product and to quantitatively select a formulation, 
optimization techniques are used which provide both depth of 
understanding and an ability to explore and define ranges for 
formulation and processing factors. It is at this point that 
optimization can become a useful tool to quantitative a formulation 
that has been qualitatively determined. 
The present investigation deals with an attempt of systematic 
formulation an approach for optimization of ibuprofen fast 
dissolving tablets employing starch xanthate, sodium starch 
glycolate, croscarmellose sodium as superdisintegrants. A 23
MATERIALS AND METHODS 
 
factorial design was applied to investigate the main and interaction 
effects of the three formulation variables i.e., starch xanthate (A), 
sodium starch glycolate (B), croscarmellose sodium (C) in each case 
to find the formula with less disintegration time and more 
dissolution efficiency 5 min and to permit arbitrary selection of 
tablets with immediate release of drug within 5 min. 
Materials 
Sodium hydroxide, Carbon disulphide, Mannitol was purchased from 
Finar chemicals Ltd, Ahmedabad. Potato starch, Ibuprofen, Sodium 
starch glycolate, Croscarmellose sodium was obtained from Yarrow 
chem. products, Mumbai. Microcrystalline cellulose was bought from 
Qualigens fine chemicals, Mumbai. Talc and magnesium stearate was 
obtained from Molychem, Mumbai. 
Preparation of starch xanthate (a novel superdisintegrant) 
Initially, 35.4 parts of potato starch were slurried in 225 ml distilled 
water and 8 parts of sodium hydroxide was dissolved in distilled 
water. Both are stirred continuously for 30 min. To this 5 parts of 
carbon, disulphide was added and stirred for 16 h at 25 °C. After 16 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                               Vol 10, Issue 6, 2018 
Kumar et al. 
Int J App Pharm, Vol 10, Issue 6, 2018, 249-258 
 
250 
h, it was filtered and washed with 75 ml of distilled water, 500 ml of 
acetone and 100 ml of ether. The product was kept in oven at 60 °C 
for 2 h. The product obtained was ground and sieved.  
Characterization of starch xanthate 
The starch xanthate prepared was evaluated for the following 
Solubility 
Starch xanthate solubility was tested in various solvents like 
distilled water, aqueous buffers of pH 1,2,3,4,6 and organic solvents 
such as alcohol, dichloromethane, chloroform, acetone and 
petroleum ether [6]. 
pH 
The pH of 1% w/v slurry was measured by pH meter [6]. 
Melting point 
Melting point was determined by using melting point apparatus [6]. 
Viscosity 
Viscosity of 1% dispersion in water was measured using Ostwald 
viscometer [6]. 
Swelling index 
Starch xanthate (200 mg) was added to 10 ml of water and light 
liquid paraffin taken in two different graduated test tubes and 
mixed. The dispersion in the tubes was allowed to stand for 12 h. 
The volumes of the sediment in the tubes were recorded. The 
swelling index ( ) of the material was calculated as follows [6].  
 
Test for gelling property 
Starch and starch xanthate prepared were evaluated for their gelling 
property by heating a 7% w/v dispersion of each in water at 100 °C 
for 30 min [6]. 
Particle size 
Particle size analysis was done by sieving using standard sieves [7]. 
Density 
Density (g/cc) was determined by liquid displacement method using 
benzene as liquid [7]. 
Bulk density 
Both loose bulk density (LBD) and tapped bulk density (TBD) were 
determined by transferring the accurate weighed amount of sample 
in 50 ml measuring cylinder, the granules without any agglomerates 
and measured the volume of packing and tapped 50 times on a plane 
surface and tapped volume of packing recorded and LBD and TBD 
calculated by following formula [7]. 
 
 
Percentage compressibility index  
Percentage compressibility of the powder mix was determined by 
Carr’s Compressibility Index calculated by the following formula [8]. 
 
Where, TBD= Tapped bulk density; LBD= Loose bulk density. 
Angle of repose 
The frictional forces in loose powder or granules can be measured 
by the angle of repose. This is the maximum angle possible between 
the surface of a mass of powder or granules and the horizontal 
plane. The angle of repose is calculated by applying the next 
equation [8]; 
  
Where θ=angle of repose; h=height; r=radius 
Fourier transform infrared (FTIR) spectroscopy 
FTIR spectra of starch xanthate were recorded on samples prepared 
in potassium bromide (KBr) disks using a BRUKER FT–IR, (Tokyo, 
Japan). The scanning range was 500 to 4000 cm-1. Samples were 
mixed with (KBr) to form disks by means of a hydrostatic press at 6-
8 tons pressure [8].  
X-Ray diffraction 
Diffraction pattern of starch xanthate was recorded with an x-ray 
diffractometer (analytical spectra’s Pvt. Ltd., Singapore). X-ray 
diffraction was performed at room temperature (30 °C) with a 
diffractometer; target, Cu(λ1.54 A), filter, Ni; voltage,40 ⱪV; current 
30 mA; time constant 10 mm/s; scanning rate 2 °/min; measured 
from 2.5-50 ° at full scale 200 [8]. 
Drug-excipient compatibility studies 
The compatibility of starch xanthate with the selected drug 
(Ibuprofen) was evaluated in DSC and FTIR studies. 
Differential scanning calorimetry (DSC) 
DSC thermograms of ibuprofen and their mixtures (1: 1) with starch 
xanthate were recorded on Perkin Elmer thermal analyser samples 
(2-5 mg) were sealed into aluminum pans and scanned at a heating 
rate of 10 °C min-1 over a temperature range 30–350 °C [8]. 
Infrared spectroscopy 
Fourier transform infrared (FTIR) spectra of ibuprofen, and their 
mixtures (1: 1) with starch xanthate were recorded on a Perkin 
Elmer, IR Spectrophotometer model: Spectrum RXI, using KBr disc 
as a reference [8]. 
Preparation of ibuprofen fast dissolving tablets 
The tablets were prepared by direct compression method employing 
23
Weight variation test was done with 20 tablets. It is the individual 
variation of the tablet weighed from the average weight of 20 tablets 
[10]. 
 factorial design in which 3 independent variables 
{superdisintegrants i.e., starch xanthate (A), sodium starch glycolate 
(B), croscarmellose sodium (C)} and 1 dependent variable (dissolution 
efficiency in 5 min) were selected. The composition of the different 
formulation of ibuprofen fast dissolving tablets is shown in table no 1 
in which the levels of superdisintegrants were selected at 2 levels i.e., 
lower and higher level concentrations. For starch xanthate (A), the 
lower level i.e., 5% concentration and upper level i.e., 10% 
concentration. For sodium starch glycolate (B) and croscarmellose 
sodium(C), the lower level is zero concentration and higher level i.e., 
5% concentration. For uniformity in particle size, each ingredient was 
passed through # 100 mesh sized screen before mixing. Starch 
xanthate, sodium starch glycolate, croscarmellose sodium, mannitol 
and microcrystalline cellulose were accurately weighed and mixed 
using mortar and pestle, and the added to ibuprofen. Finally, talc and 
magnesium stearate were added to the powder mixture. Finally, the 
mixed blend was compressed by using eight station rotator press 
Karnawathi Machineries Pvt, Ltd., Ahmedabad, India). 
Evaluation of ibuprofen fast dissolving tablets 
Hardness test 
Hardness indicates the ability of a tablet to withstand mechanical 
shocks while handling. The hardness of the tablet was determined 
using Monsanto hardness tester and expressed in kg/cm² [9]. 
Uniformity of weight 
Kumar et al. 
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Table 1: Formulae of ibuprofen fast dissolving tablets employing starch xanthate prepared by direct compression method involving 
mannitol as a diluent 
Ingredients  F1 F2 F3 F4 F5 F6 F7 F8 F9 
Ibuprofen 100 100 100 100 100 100 100 100 100 
Starch xanthate 25 50 25 50 25 50 25 50 --- 
Sodium starch glycolate --- --- 25 25 --- --- 25 25 --- 
Croscarmellose sodium --- --- --- --- 25 25 25 25 --- 
Mannitol 155 130 130 105 130 105 105 80 180 
Micro crystalline cellulose 200 200 200 200 200 200 200 200 200 
Talc 10 10 10 10 10 10 10 10 10 
Magnesium stearate 10 10 10 10 10 10 10 10 10 
Total 500 500 500 500 500 500 500 500 500 
 
Friability 
The friability of tablets was measured using a Roche fribilator. 
Tablets were rotated at 25 rpm for 4 min or up to 100 revolutions. 
The tablets were then reweighed after removal of fines and the 
percentage of weight loss was calculated [10]. 
F  
Drug content uniformity 
For content uniformity, ten tablets were weighed and powdered a 
quantity of powder equivalent to 10 mg of ibuprofen was extracted 
into 7.2 phosphate buffer and filtered. The ibuprofen content was 
determined by measuring the absorbance spectrophotometrically at 
221 nm after appropriate dilution with 7.2 phosphate buffer. The 
drug content was calculated as an average of three determinations 
[10]. 
Wetting time 
The wetting time of tablets was measured by placing five circular 
tissue papers in a petri dish of 10 cm in diameter. Ten ml of water 
containing a water-soluble dye (amaranth) was added to the petri 
dish. A tablet was carefully placed on the tissue paper. The time 
required for water to reach the upper surface of the tablet was noted 
as wetting time [11, 12].  
Water absorption ratio 
A piece of tissue paper folded was kept in a small petri dish to which 
6 ml of water was added. A tablet was kept on the tissue paper and 
allowed to completely wet. The wetted tablet was then weighed. 
Water absorption ration R was determined using the following 





 = weight of tablet after water absorption. 
2
In–vitro disintegration time 
 = weight of tablet before water absorption. 
Disintegration time for FDTs was determined using USP 
disintegration apparatus 0.1 N HCl buffer. The volume of medium 
was 900 ml and the temperature was 37±0.2 °C. The time taken for 
complete disintegration of the tablet was measured [13]. 
In–vitro dissolution studies 
The in vitro dissolution rate study of ibuprofen fast dissolving tablets 
were performed using 8 stage dissolution test apparatus (Electrolab 
TDT-08L) fitted with paddles (50 rpm) at 37±0.5 °C, using 7.2 phosphate 
buffer (900 ml) as a dissolution media. At the predetermined time 
intervals, 5 ml samples were withdrawn, filtered through a 0.45µ 
membrane filter, diluted and assayed at 221 nm using an Analytical 
technology T360 UV/Visible Double beam spectrophotometer. 
Cumulative percentage release was calculated using standard 
absorbance from the calibration curve. All the dissolution experiments 
were conducted in triplicate (n = 3) [13]. 
RESULTS AND DISCUSSION 
The starch xanthate prepared was found to be fine, free-flowing 
slightly crystalline powder. The physical and micromeritic properties 
of the starch xanthate are summarized in table 2. It was insoluble in 
aqueous solvents and insoluble in organic solvents tested (methanol, 
petroleum ether, dichloromethane, and chloroform). The pH of 0.1% 
aqueous dispersion was found to be 6.194±0.001.  
Starch xanthate exhibited good swelling in water. The swelling index 
was found to be 50±0.003% indicating that it is suitable for 
superdisintegrant. All micrometric properties indicated good flow 
properties needed manufacturing of tablets. The density of starch 
xanthate was found to be 0.9848±0.0004g/cc. The angle of repose and 
compressibility index showed good flow properties of starch xanthate. 
The FTIR spectrum of potato starch and starch xanthate is shown in 
fig. 1 and 2. The presence of peaks absorption at 1634.10 cm-1
 
 
characteristic peak of ester, so from FTIR studies it was concluded that 
starch xanthate (ester) was formed when starch was allowed to react 
with formic acid. The X-ray diffraction pattern (fig. 3) of starch 
xanthate showed characteristic peaks, which indicates that the 
structure is slightly crystalline. As the starch xanthate was slightly 
crystalline powder and it had got all the characteristic of 
superdisintegrants it was concluded that starch xanthate can be used 
as novel superdisintegrant in the formulation of fast dissolving tablets. 
Table 2: Physical and micromeritic properties of the starch xanthate prepared 
Parameters Observation 
Solubility Insoluble in all aqueous and organic solvents tested 
pH(1% w/v aqueous dispersion) 6.194±0.001 
Melting point ( °C) 218±0.002 
Viscosity(1% w/v aqueous dispersion) (cps) 1.016±0.005  
Swelling index (%) 50±0.003 
Gelling property No gelling and the swollen particles of starch xanthate separated from water. Where as in the 
case of starch, it was gelatinized and formed gel. 
Particle size (µm) 80±0.06 
Density (g/cc) 0.9848±0.0004 
Bulk density (g/cc) 0.625±0.007 
Angle of repose ( °) 12.4±0.07 
Compressibility index (%) 32.5±0.07 
*SD standard deviation from mean, n=3 
Kumar et al. 




Fig. 1: Fourier transform infrared spectra of potato starch 
 
 
Fig. 2: Fourier transform infrared spectra of starch xanthate 
 
 
Fig. 3: X-ray diffraction pattern of starch xanthate 
Kumar et al. 
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The X-ray diffraction pattern of starch xanthate showed 3 
characteristic peaks, which indicates that structure is slightly 
crystalline. The compatibility of starch xanthate with the selected 
drug (Ibuprofen) was evaluated by DSC, FTIR studies. The DSC 
thermograms of ibuprofen and ibuprofen–starch xanthate are 
shown in fig. 4 and 5. The DSC thermograms of ibuprofen and 
ibuprofen–starch xanthate exhibited exothermic peaks at 83.34 °C 
and 63.13 °C respectively. These melting peaks of ibuprofen and 
ibuprofen–starch xanthate are nearer to the melting points of 
ibuprofen (75-78 °C). The peaks observed in the DSC thermograms 
of ibuprofen and ibuprofen–starch xanthate mixtures correspond to 
the melting points of the respective drug indicating no interactions 
between the selected drug and starch xanthate polymer. The DSC 
study indicated no interaction between starch xanthate and the 
selected drug. 
The FTIR spectra of ibuprofen and ibuprofen–starch xanthate are shown 
in fig. 6 and 7. The characteristic FTIR bands of ibuprofen at 1718.78 cm-
1 (COOH), and ibuprofen–starch xanthate at 1716.17 cm-1
Thus, the results of DSC and FTIR indicated no interaction between 
the selected drug and starch xanthate, the new superdisintegrant. 
Hence, starch xanthate could be used as a superdisintegrant in the 
design of fast dissolving tablets of the selected drug. 
(COOH)were all 
observed in the FTIR spectra of both ibuprofen and ibuprofen–starch 
xanthate. These FTIR spectra observations also indicated no interaction 
between starch xanthate and the drug selected. 
  
 
Fig. 4: DSC thermo gram of ibuprofen pure drug 
 
 
Fig. 5: DSC thermo gram of ibuprofen with starch xanthate 
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Fig. 6: FTIR spectra of ibuprofen 
 
 
Fig. 7: FTIR spectra of ibuprofen with starch xanthate 
 
Evaluation of tablets 
Hardness 
The hardness of tablets from all batches was found to be in the range 
of 3.6±0.03 kg/cm2 to 4±0.01 kg/cm2
Friability 
. All tablets were found hard 
enough so that they could easily withstand the handling and storage 
conditions without getting broken. 
All the tablets exhibited acceptable friability as none of the tested 
batches showed percentage friability that exceeded 1%. The percent 
friability of all batches found in the range of 0.12%-0.15% indicating 
good mechanical resistance of tablets. Thus, it was proved that 
tablets could withstand the pressure, mechanical shocks during 
handling, transportation, storage and manufacturing processes. 
Drug content 
Drug content of all the formulation batches was found to be between 
97.34±0.71 to 99.83±0.56. Hence, it can be concluded that all the 
formulations are having an accurate amount of drug distributed 
uniformly in powder mass and followed acceptable limits as per IP 
[14]. i.e. 85 to 115 % of average content table 3. 
Disintegration studies 
In vitro disintegration time was done by the USP dissolution apparatus. 
The disintegration rate has a correlation with water absorption 
capacity of disintegrate and The In vitro disintegration time was found 
between 12±0.02 to 312±0.02s. The outcomes were tabulated and 
data demonstrated in table 3. All the formulation showed 
disintegration time of less than 180s. It was found that the formulation 
F5 will show least disintegration time 12s as compare to other 
formulation. The order for a disintegration time in the fast dissolving 
tablet was found to be F5<F6<F7<F8<F3<F4<F2<F1<F9. The order of 
disintegration time may be due to the interaction and main effects of 
the super disintegrants used in the fast dissolving tablets. 
Water absorption ratio and wetting time 
The water absorption ratio founded from 16±0.16 to 174±0.21s. This 
increased behavior due to the water taking the ability of super 
disintegrants. The wetting time found between 76±0.21 to 217±0.17s. 
Kumar et al. 
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The outcomes were tabulated and data demonstrated in table 3 and fig. 
8, 8a and 8b. It was found that the formulation F5 containing 5 % starch 
xanthate and 5 % croscarmellose sodium showed less wetting time i.e. 
76±0.21s as compared to other formulations. 
In vitro dissolution studies 
Dissolution rate depends on the wetting time of the disintegrant, 
among all the formulations F5 has less wetting time and has greater 
dissolution rate and then this is the other conformance test for 
correct selection of desirable. In vitro dissolution studies of all the 
formulation were done and depicted in fig. 9. In all formulations F5 
formulation was selected as the promising formulation containing 5 
% starch xanthate and 5 % croscarmellose sodium with 99.84% 
release in 5 min which may be due to the interaction effect between 
the two super disintegrants i.e., starch xanthate and croscarmellose 
sodium at a concentration of 5 % each.  
The dissolution parameters of the formulation from (F1–F9) which 
were made by direct compression method were shown in the table: 
4. In all these cases the PD5 (percent dissolved in 5 min) was more in 
F5 which consists at 5% starch xanthate, and 5% croscarmellose 
sodium. The same was in the case of DE5% (dissolution efficiency in 
5 min). The PD5 and DE5% revels that starch xanthate was effective 
at 5% along with 5% croscarmellose sodium when the formulations 
were made by direct compression using these superdisintegrants. 
The K1 decreased in all the formulation when compared to F9 
formulation which was given in table 4. The number of folds 
increases in DE5% and number of folds increase in K1 (min-1) were 
given to the table 4. From the results, it was concluded that starch 
xanthate (new super disintegrant) could be used as a super 
disintegrant in the formulation of fast dissolving tablets of 
ibuprofen. To evaluate the individual and combined effects of the 
three factors involved, fast dissolving tablets were formulated 
employing selected combinations of the factors as per 23-factorial 
design. The fast dissolving tablets and release parameters (percent 
drug released in 5 min) of the fast dissolving formulated were 
analyzed as per ANOVA of 23
Fast dissolving tablets formulated employing starch xanthate (5%), 
sodium starch glycolate (5%) and croscarmellose sodium (5%) as 
super disintegrants exhibited in disintegration and dissolution 
efficiency in 5 min. Formulation F5 gave release of 99.84% in 5 min 
fulfilling the official specification, based on disintegration time and 
dissolution efficiency in 5 min. Formulation F5 is considered as a 
good fast dissolving tablet formulations of ibuprofen which was 
found to better than the ibuprofen fast dissolving tablets formulated 
by Purkayastha et al. [15]. 
-factorial design. ANOVA of fast 
disintegrating times (table 5) indicated that the individual effects of 
starch xanthate (A), sodium starch glycolate (B) and croscarmellose 
sodium (C), as well as the combined effects of AB, AC, BC and ABC 
factors, were significant (P<0.05) on disintegration time and 
dissolution efficiency in 5 min of ibuprofen fast dissolving tablets.  
 
Table 3: Physical properties: hardness, friability drug content of ibuprofen fast dissolving tablets prepared by direct compression method 





Drug content mg/tab) 
n±SD 
Disintegration time (sec) 
n±SD 
Water absorption ratio 
(%) n±SD 
F1 3.9±0.01 0.12±0.013 97.58±0.71 219±0.02 133±0.12 
F2 3.6±0.03 0.13±0.015 98.1±0.79 213±0.03 127±0.18 
F3 4.0±0.01 0.14±0.012 99.45±0.63 58±0.02 16±0.16 
F4 3.8±0.04 0.12±0.014 98.56±0.55 91±0.02 97±0.15 
F5 3.7±0.03 0.14±0.012 99.83±0.56 12±0.01 174±0.21 
F6 3.9±0.01 0.15±0.012 99.34±0.18 14±0.02 141±0.12 
F7 3.7±0.02 0.14±0.014 99.56±0.57 19±0.01 91±0.15 
F8 4.0±0.04 0.12±0.013 99.17±0.11 27±0.02 98±0.27 
F9  3.6±0.03 0.12±0.013 97.34±0.71 312±0.02 74±0.12 
*SD standard deviation from mean, n=3, mean±SD. 
 
 
Fig. 8: Wetting time of ibuprofen fast dissolving tablets prepared employing starch xanthate involving mannitol as a diluents 
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Fig. 8a: Wetting time of ibuprofen fast dissolving tablets prepared employing starch xanthate involving mannitol as a diluents 
 
 
Fig. 8b: Wetting time of ibuprofen fast dissolving tablets prepared employing starch xanthate involving mannitol as a diluents 
 
 
Fig. 9: Dissolution profiles of ibuprofen fast dissolving tablets prepared employing starch xanthate involving mannitol as a diluent (F1-
F9) (n=3, mean±SD) 
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Fig. 10: Time Vs
 
 Log percent drug undissolved plots for ibuprofen fast dissolving tablets prepared employing starch xanthate involving 
mannitol as a diluent (F1-F9) (n=3, mean±SD) 
Table 4: Dissolution parameters of ibuprofen fast dissolving tablets formulated employing starch xanthate and other known 
superdisintegrants prepared by direct compression involving mannitol as a diluent 
Time (min) F1 F2 F3 F4 F5 F6 F7 F8 F9 
PD 0.93±0.11 5 3.16±0.63 15.41±0.51 33.85±0.47 99.84±0.19 53.53±0.23 99.17±0.46 31.76±0.28 36.98±0.31 
DE5 8.3±0.22 % 5.9±0.15 12.8±0.32 14.4±0.45 48.6±0.59 48.6±0.59 48.6±0.59 11.3±0.43 3.7±0.19 





0.43 0.93 1.05 3.54 3.54 3.54 0.82 - 
K1 (min-1 0.01±0.002 ) 0.02±0.004 0.04±0.007 0.05±0.007 - 0.10±0.008 - 0.07±0.003 0.16±0.009 
 *SD standard deviation from mean, n=3, mean±SD, PD5-Percent dissolved in 5 min., DE5%-Dissolution efficiency in 5 min., K1
 
 =First order rate 
constant 
Table 5: ANOVA of dissolution efficiency in 5 min of ibuprofen fast dissolving tablets formulated employing starch xanthate involving 
mannitol as a diluent 
Source of variation d. f. S. S. M. S. S. Variance ratio Result 
Replicates 2 1.73 0.86 01.34 P ˃ 0.05 
Treatments 7 8407.59 1201.08 1876.68 P ˂ 0.05 
Starch xanthate (5%) 1 14865.30 14865.30 23227.03 P ˂ 0.05 
Starch xanthate (10%) 1 559.70 559.70 874.53 P ˂ 0.05 
Starch xanthate (5%) X Sodium starch glycolate (5%) 1 219.01 219.01 342.20 P ˂ 0.05 
Starch xanthate (10%) X Sodium starch glycolate (5%) 1 434.35 434.35 678.67 P ˂ 0.05 
Starch xanthate (5%) X Croscarmellose sodium (5%) 1 5095.42 5095.42 7961.59 P ˂ 0.05 
Starch xanthate (10%) X Croscarmellose sodium (5%) 1 506.92 506.92 792.06 P ˂ 0.05 
Starch xanthate (5%) X Sodium starch glycolate (5%) X 
Croscarmellose sodium (5%) 
1 923.80 923.80 1443.43 P ˂ 0.05 
Starch xanthate (10%) X Sodium starch glycolate (5%) X 
Croscarmellose sodium (5%) 
1 654.17 654.17 1022.145 P ˂ 0.05 
Error 14 9.09 0.64 -- -- 
Total 23 -- -- -- -- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom *S. S–Sum of Square 
*M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance 
 
CONCLUSION 
Starch xanthate is an efficient superdisintegrant for fast 
dissolving tablets. The disintegration and dissolution efficiency 
of the fast dissolving tablets of ibuprofen was good and 
depended on the concentration of superdisintegrant employed 
i.e., starch xanthate (5%), and croscarmellose sodium (5%). The 
formulated fast dissolving tablets of ibuprofen employing starch 
xanthate and croscarmellose sodium exhibited good dissolution 
efficiency in 5 min which can be used for the fast therapeutic 
action of ibuprofen.  
Overall, Starch xanthate was found to be a super-disintegrant when 
combined with croscarmellose sodium, the dissolution efficiency of 
ibuprofen was enhanced and hence it could be used in the 
formulation of fast dissolving tablets to provide immediate release 
of the contained drug within 5 min. 
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